M
10b5-1 Plan
$ Value
$0
Shares
2,170
Price
$0
Filed
Apr 13
Insider
Name
Rodman David Malcom
Title
Chief Medical Officer
CIK
0001672659
Roles
Officer
Transaction Details
Transaction Date
2026-04-09
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
21,706
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025. | The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.
Filing Info
Rodman David Malcom's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-17 | MLYS | M | $6K |
| 2026-04-17 | MLYS | ▼ | $13K |
| 2026-04-17 | MLYS | M | $0 |
| 2026-04-15 | MLYS | ▼ | $176K |
| 2026-04-13 | MLYS | M | $7K |
| 2026-04-13 | MLYS | M | $36K |
| 2026-04-13 | MLYS | M | $59K |
| 2026-04-13 | MLYS | ▼ | $373K |
| 2026-04-13 | MLYS | M | $0 |
| 2026-04-13 | MLYS | M | $0 |
Other Insiders at MLYS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $8.8M | — | 2026-03-30 |
|
Congleton Jon
Chief Executive Officer
|
— | $2.4M | 2026-04-13 |
|
Rodman David Malcom
Chief Medical Officer
|
— | $621K | 2026-04-17 |
| Karydas Daphne | — | $75K | 2026-03-31 |